IDH1 and cancer: It is understood that R‐2‐HG interferes with the activity of multiple α‐KG‐dependent hydroxylases, exerting metabolic and epigenetic reprogramming of IDH‐mutant cancer cells, in addition to inducing paracrine effects on the TME [28].